PMID: 6164480May 1, 1981Paper

The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study

Cancer
G J D'AngioJ Wolff

Abstract

One-hundred-eighty-eight children up to 16 years of age were randomized in the second National Wilms' Tumor Study (NWTS) with tumors that were confined to the kidney and that had been totally excised (Group I). Most fared well whether treated for six or for 15 months with both actinomycin D (AMD) and vincristine (VCR). No postoperative radiation therapy (RT) was given. The two-year relapse-free survival (RFS) and two-year survival rates were 88 and 95%, respectively. Two-hundred-sixty-eight randomized patients with more advanced local lesions (Groups II and III) and 57 with distant metastases (Group IV) had postoperative RT and were scheduled for 15 months treatment with either AMD and VCR (Reg. C) or AMD plus VCR plus Adriamycin (Reg. D). The 77% two-year RFS rate for Reg. D was significantly different from the 63% with Reg. C. As in the first NWTS, patients with tumors of unfavorable histology (UH) had a significantly worse prognosis than those with favorable histology (FH), as did those with positive nodes. Survival rates at two years were 54% for UH vs. 90% for FH, and 54% vs. 82% for those with and without lymph node involvement.

References

Oct 1, 1977·Journal of Pediatric Surgery·H C BishopG J D'Angio
May 1, 1977·International Journal of Radiation Oncology, Biology, Physics·M Tefft
Sep 1, 1978·International Journal of Radiation Oncology, Biology, Physics·G J D'AngioJ A Meyer
Feb 1, 1970·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·M TefftR M Filler
Sep 1, 1974·Annals of Internal Medicine·S S DonaldsonJ R Wilbur
Apr 1, 1980·Cancer·G J D'AngioJ A Wolff

❮ Previous
Next ❯

Citations

Oct 1, 1989·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·M BarreraM Stevens
Sep 1, 1990·The Japanese Journal of Surgery·A KumarB Kapur
Feb 6, 1999·International Urology and Nephrology·M AkmansuE Tülay
Jan 1, 1996·International Urology and Nephrology·P WinterU Hellerich
Jan 1, 1997·International Urology and Nephrology·M AkmansuT Evrenkaya
Jan 1, 1992·Urologic Radiology·B Cushing, T L Slovis
Jan 24, 2007·Der Urologe. Ausg. A·V ZugorG E Schott
Nov 21, 2007·Pediatric Radiology·Sue C KasteHelen Jenkinson
Nov 21, 2007·Lifetime Data Analysis·Giulio J D'Angio
Oct 1, 1983·Cancer Genetics and Cytogenetics·Y KanekoH S Maurer
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S S de GraafA Postma
May 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G LevittB Whitehead
Mar 1, 1995·Critical Reviews in Oncology/hematology·M J Coppes
Aug 1, 1997·Pediatric Clinics of North America·M J Petruzzi, D M Green
Dec 19, 2003·The Urologic Clinics of North America·Farzeen Firoozi, Barry A Kogan
Oct 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A C PaulinoL E Kun
May 29, 1999·International Journal of Radiation Oncology, Biology, Physics·J A MeiselD M Green
Mar 22, 2000·International Journal of Radiation Oncology, Biology, Physics·A C PaulinoD H Hussey
Jan 1, 2004·The Lancet Oncology·John A KalapurakalMax J Coppes
Nov 3, 2005·Nature Clinical Practice. Oncology·Lyndon M GommersallPatrick Duffy
Oct 7, 2008·Nature Clinical Practice. Urology·Geoffrey Sonn, Linda M D Shortliffe
Sep 24, 1981·The New England Journal of Medicine·T F Ackerman, A M Mauer
Feb 25, 1999·Journal of Pediatric Hematology/oncology·L M PirichD O Walterhouse
May 7, 2009·Current Opinion in Pediatrics·Andrew M Davidoff
Jan 20, 2010·Annals of Surgery·Mehul V RavalMarleta Reynolds
Mar 12, 2011·Annals of Surgery·Thomas E HamiltonRobert C Shamberger
Sep 1, 1992·British Journal of Urology·G WilliamsN F Gowing
Dec 1, 1992·British Journal of Urology·B DelahuntJ Fraser
Sep 1, 1990·Archives of Disease in Childhood·J J Groot-LoonenJ Pritchard
Sep 1, 1992·Archives of Disease in Childhood·C R Pinkerton
Nov 1, 1986·The Journal of Clinical Investigation·N A Berger
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel M GreenNorman E Breslow
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cecilia A CottonNorman E Breslow
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm A SmithGregory H Reaman
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel M GreenNorman E Breslow
Oct 1, 2007·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Hemant B TongaonkarThyavihalli B Yuvaraja
Feb 24, 2010·Journal of Indian Association of Pediatric Surgeons·Sushmita Bhatnagar
Jan 1, 1989·Acta Oncologica·M P MehtaK Bertelrud
Jul 1, 1987·The American Journal of the Medical Sciences·B L Powell, J B Craig
Jan 22, 2013·Journal of Pediatric Surgery·Robert C Shamberger
Apr 1, 1986·Mayo Clinic Proceedings·B H Kaufman
Jun 5, 2012·International Journal of Radiation Oncology, Biology, Physics·John A KalapurakalPaul E Grundy
Jan 22, 2013·Journal of Pediatric Surgery·Daniel M Green

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.